Sanofi Consumer Healthcare India reports over two-fold jump in Q2 net profit

Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 544250 | NSE: SANOFICONR

05 Aug 2025 Evaluate

Sanofi Consumer Healthcare India has reported result for second quarter ended June 30, 2025.

The company has reported over two-fold jump in its net profit at Rs 60.70 crore for the quarter ended June 30, 2025 as compared to Rs 29 crore for the same quarter in the previous year. The total income of the company increased by 30.85% at Rs 226.50 crore for the quarter ended June 30, 2025 as compared to Rs 173.10 crore for the corresponding quarter previous year.

Sanofi Consumer Healthcare India is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals.

Peers

Company Name	CMP
Sun Pharma. Inds.	1842.00
Dr. Reddys Labs.	1161.00
Cipla	1365.00
Lupin	2096.00
Zydus Lifesciences	1119.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.